Trial_ID stringclasses 7
values | Patient_ID stringlengths 4 4 | Drug_A_Dosage_mg int64 100 220 | Drug_B_Dosage_mg int64 40 100 | Age_Years int64 35 77 | BMI float64 21.5 35.2 | Baseline_Condition_Score float64 4 9.9 | Response_Category stringclasses 4
values | Adverse_Events_Count int64 0 4 | Primary_Endpoint_Value float64 0.01 0.98 | Time_to_Relapse_Days int64 15 600 |
|---|---|---|---|---|---|---|---|---|---|---|
TRIAL001 | P001 | 150 | 50 | 62 | 28.5 | 7.8 | Complete Response | 1 | 0.92 | 450 |
TRIAL001 | P002 | 150 | 50 | 45 | 24.1 | 6.5 | Partial Response | 0 | 0.45 | 180 |
TRIAL001 | P003 | 150 | 50 | 71 | 32.9 | 9.1 | Stable Disease | 3 | 0.15 | 90 |
TRIAL001 | P004 | 150 | 50 | 55 | 26.7 | 5.9 | Complete Response | 0 | 0.88 | 510 |
TRIAL001 | P005 | 150 | 50 | 38 | 22.3 | 4.2 | No Response | 0 | 0.05 | 30 |
TRIAL002 | P006 | 200 | 75 | 58 | 30.1 | 8.5 | Partial Response | 2 | 0.61 | 240 |
TRIAL002 | P007 | 200 | 75 | 67 | 27.8 | 7.3 | Complete Response | 1 | 0.95 | 600 |
TRIAL002 | P008 | 200 | 75 | 51 | 25.5 | 5.1 | Stable Disease | 0 | 0.33 | 120 |
TRIAL002 | P009 | 200 | 75 | 74 | 35.2 | 9.8 | No Response | 4 | 0.01 | 15 |
TRIAL002 | P010 | 200 | 75 | 41 | 23.9 | 6 | Partial Response | 0 | 0.55 | 210 |
TRIAL003 | P011 | 100 | 100 | 60 | 29.3 | 8 | Complete Response | 0 | 0.98 | 550 |
TRIAL003 | P012 | 100 | 100 | 49 | 25 | 7 | Partial Response | 1 | 0.52 | 160 |
TRIAL003 | P013 | 100 | 100 | 77 | 31.5 | 9.5 | Stable Disease | 2 | 0.2 | 80 |
TRIAL003 | P014 | 100 | 100 | 53 | 24.8 | 5.5 | Complete Response | 0 | 0.85 | 480 |
TRIAL003 | P015 | 100 | 100 | 44 | 26 | 6.2 | No Response | 0 | 0.1 | 45 |
TRIAL004 | P016 | 175 | 60 | 65 | 33 | 8.9 | Partial Response | 3 | 0.7 | 280 |
TRIAL004 | P017 | 175 | 60 | 40 | 21.5 | 4 | Complete Response | 0 | 0.9 | 530 |
TRIAL004 | P018 | 175 | 60 | 70 | 29.9 | 7.5 | Stable Disease | 1 | 0.3 | 100 |
TRIAL004 | P019 | 175 | 60 | 57 | 27 | 6.8 | No Response | 0 | 0.12 | 50 |
TRIAL004 | P020 | 175 | 60 | 48 | 25.5 | 5.2 | Partial Response | 1 | 0.65 | 220 |
TRIAL005 | P021 | 120 | 80 | 63 | 28 | 7.9 | Complete Response | 1 | 0.94 | 470 |
TRIAL005 | P022 | 120 | 80 | 42 | 23.5 | 6.1 | Partial Response | 0 | 0.48 | 190 |
TRIAL005 | P023 | 120 | 80 | 75 | 34 | 9.9 | Stable Disease | 2 | 0.18 | 70 |
TRIAL005 | P024 | 120 | 80 | 50 | 26.2 | 5.8 | Complete Response | 0 | 0.82 | 490 |
TRIAL005 | P025 | 120 | 80 | 35 | 21.9 | 4.5 | No Response | 0 | 0.08 | 35 |
TRIAL006 | P026 | 220 | 40 | 68 | 30.5 | 8.8 | Partial Response | 3 | 0.58 | 250 |
TRIAL006 | P027 | 220 | 40 | 47 | 24.4 | 5 | Complete Response | 0 | 0.87 | 500 |
TRIAL006 | P028 | 220 | 40 | 72 | 32 | 9.3 | Stable Disease | 1 | 0.25 | 95 |
TRIAL006 | P029 | 220 | 40 | 54 | 26.9 | 6.4 | No Response | 2 | 0.03 | 20 |
TRIAL006 | P030 | 220 | 40 | 39 | 22.8 | 4.1 | Partial Response | 0 | 0.4 | 150 |
TRIAL007 | P031 | 160 | 70 | 61 | 27.5 | 7.7 | Complete Response | 1 | 0.91 | 460 |
TRIAL007 | P032 | 160 | 70 | 46 | 24 | 6.6 | Partial Response | 0 | 0.46 | 170 |
No dataset card yet
- Downloads last month
- 3